Related Experiment Video
Updated: Dec 3, 2025

09:51
Microfluidic Production of Lysolipid-Containing Temperature-Sensitive Liposomes
Published on: March 3, 2020
9.5K
Continuous-Flow Production of Liposomes with a Millireactor under Varying Fluidic Conditions
Fatih Yanar1, Ali Mosayyebi1, Claudio Nastruzzi2
1Bioengineering Science Group, Faculty of Engineering and Physical Sciences, University of Southampton, Southampton SO17 1BJ, UK.
Pharmaceutics
|October 27, 2020
Summary
Millimeter-scale flow reactors offer a scalable and cost-effective method for producing nanoscale liposomes. This millireactor technology yields liposomes with therapeutically relevant size and dispersity, outperforming traditional batch methods.
Area of Science:
- Nanotechnology
- Chemical Engineering
- Materials Science
Background:
- Microfluidic reactors offer advantages for continuous-flow liposome production over batch methods.
- Challenges in scaling microfluidics for industrial liposome production include low rates, limited lifetimes, and high costs.
Purpose of the Study:
- To investigate millimeter-scale flow reactors (millireactors) as a scalable and cost-effective route for nanoscale liposome production.
- To evaluate the impact of various parameters on liposome characteristics using millireactor technology.
Main Methods:
- Utilized millimeter-scale flow reactors with a serpentine architecture for liposome synthesis.
- Investigated effects of flow rates, lipid type/concentration, storage, and temperature on liposomes.
- Characterized liposomes using dynamic light scattering (DLS), z-potential, and transmission electron microscopy (TEM).
Main Results:
- Liposome size and dispersity were significantly influenced by lipid type, concentration, and inlet flow settings.
- The millireactor produced liposomes with sizes ranging from 54 to 272 nm and dispersity from 0.04 to 0.52.
- Operating flow rates ranged from 1 to 10 mL/min.
Conclusions:
- Millireactor technology presents a viable, scalable, and cost-effective approach for producing nanoscale liposomes.
- Millifluidic reactors generated liposomes with improved size and dispersity compared to batch ethanol-injection methods.
- This technology holds promise for industrial-scale liposome manufacturing with enhanced therapeutic relevance.

